Noshin Noorjahan

[Nature Communications] Researchers found that innate lymphoid cells (ILCs) in AML patients are impaired, with reduced total ILC1 numbers and diminished function.

[Stem Cells International] GDF15 expression in colorectal cancer was analyzed using public databases and validated in patient tissues by Western blot.

[Journal of Investigative Dermatology] By integrating in vivo animal studies in a genetic mouse model of basal cell carcinoma (BCC) with analyses of human BCC specimens, the authors demonstrated that the deiodinase type 3 is expressed in the most tumorigenic CSC subpopulation.

[Nature Communications] Scientists showed that low SUCNR1 represents a marker for reduced overall and progression-free survival in AML patients.

[Nature Cell Biology] The authors analyze recent advances in understanding the metabolic landscape of HSCs, emphasizing how their intrinsic bioenergetic programs facilitate quiescence, self-renewal, and differentiation.

[Proceedings of The National Academy of Sciences of The United States of America] Using optimized single-cell technologies across three major AML subtypes, researchers found that AML-causing fusion transcription factors are expressed not only in leukemia blasts but also in seemingly normal, mature immune cells.